Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1071 per EA under NDC 31722057130. Its NADAC has been published 269 times since Jun 30, 2021.
FDA first approved this application on May 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722057130
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203083FDA Approved
5/18/2020
TE Code
AB
On Market Since
5/18/2020
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 269 times since Jun 30, 2021, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1071 per EA |
|---|---|
| All-time high | $0.1646 (Nov 10, 2021) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1089 |
| 52-week low | $0.1049 |
| Median price | $0.1093 |
| Average price | $0.1132 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 269 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.1071 per EA (NDC 31722057130), effective Aug 19, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 30.2%. It has been tracked across 269 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Jun 30, 2021, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.1646 (Nov 10, 2021), with a median of $0.1093 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 31722057130) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.